Medcom Tech

Medcom Tech Financial Leverage

Delisted

The Financial Leverage (Equity Multiplier) of Medcom Tech (MED.MC) as of Sep 17, 2026 is 27.27. In the previous year, Financial Leverage (Equity Multiplier) was 10.04 — a change of 171.50% (higher).

Financial Leverage

27.27

YoY

171.50%

Last updated:

Financial Leverage (Equity Multiplier) of Medcom Tech is 2026 27.27 . Financial Leverage (Equity Multiplier) of Medcom Tech was 2025 10.04 . It decreases by 171.50% higher compared to the previous year.

The Medcom Tech Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2015
3.23 EUR
Jan 1, 2016
4.55 EUR
Jan 1, 2017
3.48 EUR
Jan 1, 2018
6.14 EUR
Jan 1, 2019
3.81 EUR
Jan 1, 2020
6.07 EUR
Jan 1, 2021
10.04 EUR
Jan 1, 2022
27.27 EUR
The Medcom Tech Financial Leverage history
YEARFinancial LeverageYoY
27.27+171.50%
10.04+65.58%
6.07+59.23%
3.81-37.93%
6.14+76.54%
3.48-23.66%
4.55+40.89%
3.23+62.08%
1.99
Access this data via the Eulerpool API

Medcom Tech Stock analysis

What does Medcom Tech do? Medcom Tech SA is a European company headquartered in Switzerland that specializes in the development and manufacturing of medical devices. The company was founded in 1999 and has since had an impressive history. The business model of Medcom Tech SA is based on the idea of developing medical devices that meet the needs of doctors and patients. The company works closely with medical professionals to find innovative solutions that can improve medical care and accelerate patient recovery. The goal of Medcom Tech SA is to offer high-quality, safe, and reliable products that can be used worldwide in medical practice. Medcom Tech SA offers a wide range of products divided into various sectors. One of the main sectors of the company is gastroenterology, where endoscopic devices and accessories are manufactured and distributed. These devices are a crucial foundation for the diagnosis and treatment of gastrointestinal diseases. The endoscopes enable more precise interventions and are particularly in demand for minimally invasive procedures. Another important sector of the company is cardiology. Medcom Tech SA manufactures defibrillators and implantable devices in this sector. These devices help save lives and provide patients with more security in their daily lives. In particular, implantable devices are an essential part of modern medicine and contribute to allowing patients to lead long and healthy lives. In addition to the mentioned sectors, Medcom Tech also develops and produces devices for the diagnosis and treatment of respiratory diseases, neurology, gynecology, and urology. For example, in urology, a product called ProstateCare has been developed, which is an innovative method for treating benign prostatic hyperplasia (BPH), a benign enlargement of the prostate gland. Medcom Tech SA receives support in these business sectors from a network of international distribution partners who help distribute the products worldwide. In conclusion, Medcom Tech SA has undergone an impressive development and is one of the leading companies in the medical device industry. The company has earned an excellent reputation in the medical industry and is known for its innovative solutions and high-quality products. The continuous collaboration with medical professionals and the consistent development of new technologies and products make Medcom Tech an important partner in the medical care world. Medcom Tech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Medcom Tech stock

Financial Leverage (Equity Multiplier) of Medcom Tech is 27.27 in 2026.

Financial Leverage (Equity Multiplier) of Medcom Tech changed from 10.04 to 27.27, representing a 171.50% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Medcom Tech since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Medcom Tech with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Medcom Tech

All Key Metrics — Medcom Tech